Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Regeneron Pharmaceuticals, Inc.

NASDAQ: REGN · Life Sciences · 13 alerts · CIK 872589

Share price
$952.40Close, Nov 16
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Regeneron Pharmaceuticals, Inc. filings on SEC EDGAR ↗

4:14 PM ET 8-K
Stock Plan Amendment

Regeneron Pharmaceuticals Stock Plan Amendment

Regeneron granted one-time, 10-year performance share units (PSUs) to its CEO and CSO, which replace their annual equity awards through 2036. The awards are 100% performance-based, tied to ambitious pipeline milestones and new product annual revenue targets of up to $30 billion. All earned shares are subject to a mandatory holding period and cannot be sold until February 2036.

Term
10 years

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.